Apheresis Market by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis), Procedure (Therapeutic Apheresis, Donor Apheresis/Apheresis Blood Donation), Technology & by Product - Global Forecast to 2020
Apheresis is an essential tool in modern medical practices in the blood industry. It is a process in which the blood of a donor/patient is passed through a medical device, which separates one or more components of the blood and returns the remaining with or without extracorporeal treatment or replacement of separated components.
The global apheresis market is expected to reach USD 2.5 billion by 2020, growing at a CAGR of 11.2% during the forecast period (2015 to 2020). The market is mainly driven by the rising incidences of blood disorders and chronic diseases, increasing demand for source plasma from biopharmaceutical companies, and increasing demand for blood for transfusion in surgical procedures and accident & trauma cases.
In this report, the apheresis market is segmented by procedure, product, technology, application, and region. The apheresis market, by procedure, is mainly segmented into apheresis/automated blood collection and therapeutic apheresis. In 2014, the automated blood collection segment accounted for the largest share of approximately 77.2% of the apheresis market, and is expected to grow at a CAGR of 10.7% during the forecast period. Growth in this segment is mainly attributed to the increasing severity of blood shortage and growing concern regarding blood safety, and increasing incidences of blood disorders and chronic diseases.
On the basis of applications, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, LDL apheresis, and others (photopheresis, lymphapheresis, and extracorporeal immunoadsorption). The plasmapheresis segment accounted for the largest share—46.5%—of the global apheresis market in 2014. The large share of plasmapheresis is attributed to the increasing demand of source plasma for transfusion from hospitals and for fractionation from biopharmaceutical companies.
In 2014, North America commanded the largest share of the global apheresis market, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 47.8% of global apheresis market in 2014. The U.S. is a prime market due to the easy access to advanced apheresis devices through well-established distribution channels, increased collection of source plasma, and increasing incidences of blood disorders and chronic diseases. On the other hand, Asia-Pacific is the fastest-growing region in the global apheresis market, mainly driven by the increasing demand of blood components for the treatment of the large patient population, increased spending capabilities of consumers on healthcare, improving healthcare infrastructure in the region, and increasing investments by leading players and respective government agencies in the region.
Major players in the apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Medica S.p.A. (Italy), Kaneka Corporation (Japan), Nikkiso Co., Ltd. (Japan) and Therakos, Inc. (U.S.).
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping greater market shares.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the apheresis market. The report analyzes the apheresis market by procedure, product, technology, and application across all regions
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the apheresis market
Market Development: Comprehensive information on the lucrative emerging markets by procedure, product, technology, application, and region
Market Diversification: Exhaustive information about new products, growing regions, recent developments, and investments in the apheresis market
Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the apheresis market
Available Customizations for This Report
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product matrix, which gives a detailed comparison of the product portfolios of each company
Further breakdown of the Rest of Asia-Pacific apheresis market into South Korea, Australia, New Zealand, and others
Detailed analysis and profiling of additional market players (up to 5)